ELANE and acute leukemia: Modulation of protease activity is suggested as a possible explanation by the reduced activity of neutrophil elastase that has been described after intensive induction chemotherapy for acute leukemia; this reduction may thus be a chemotherapy effect, but it may also be a leukemia-associated effect that persists after remission induction [49].